Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation

Thu Apr 29 2021

The combined clinical cell-cycle risk (CCR) score uses clinical and genetic factors to assess the risk of metastasis after radiation therapy in patients with prostate cancer. The CCR score has proven accurate in studies and can guide post-radiation...

Powered by Wave AI

Get AI-powered summaries and transcripts for any meeting, phone call, or podcast.

AI SummariesFull TranscriptsSpeaker Identification

Available on iOS, Android, Mac, and Windows

Get Wave AI →

No transcript available.